Implications of RNA pseudouridylation for cancer biology and therapeutics: a narrative review

被引:2
|
作者
Ding, Hanyi [1 ,2 ]
Liu, Na [3 ,5 ]
Wang, Yan [1 ,3 ]
Adam, Sofia Abdulkadir [3 ]
Jin, Jie [1 ,3 ,4 ]
Feng, Weiying [2 ]
Sun, Jie [1 ,3 ,4 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Zhejiang, Peoples R China
[2] Shaoxing Peoples Hosp, Dept Hematol, Shaoxing, Zhejiang, Peoples R China
[3] Key Lab Hematol Malignancies Diag & Treatment, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Prov Clin Res Ctr Hematol Disorders, Hangzhou, Zhejiang, Peoples R China
[5] Weifang Med Univ, Affiliated Hosp, Sch Clin Med, Dept Oncol, Weifang, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
Pseudouridine; RNA modification; Pseudouridine synthase; Cancer diagnosis; Cancer treatment; MESSENGER-RNA; URINARY PSEUDOURIDINE; SERUM PSEUDOURIDINE; MODIFIED NUCLEOTIDES; TRANSLATION CONTROL; BIOCHEMICAL MARKER; DKC1; NUCLEOSIDES; DIAGNOSIS; EXPRESSION;
D O I
10.1186/s12967-024-05687-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundPseudouridine (Psi), a C5-glycoside isomer of uridine, stands as one of the most prevalent RNA modifications in all RNA types. Distinguishing from the C-N bond linking uridine to ribose, the link between Psi and ribose is a C-C bond, endowing Psi modified RNA distinct properties and functions in various biological processes. The conversion of uridine to Psi is governed by pseudouridine synthases (PUSs). RNA pseudouridylation is implicated in cancer biology and therapeutics.ObjectivesIn this review, we will summarize the methods for detecting Psi, the process of Psi generation, the impact of Psi modification on RNA metabolism and gene expression, the roles of dysregulated Psi and pseudouridine synthases in cancers, and the underlying mechanism.MethodsWe conducted a comprehensive search of PubMed from its inception through February 2024. The search terms included "pseudouridine"; "pseudouridine synthase"; "PUS"; "dyskerin"; "cancer"; "tumor"; "carcinoma"; "malignancy"; "tumorigenesis"; "biomarker"; "prognosis" and "therapy". We included studies published in peer-reviewed journals that focused on Psi detection, specific mechanisms involving Psi and PUSs, and prognosis in cancer patients with high Psi expression. We excluded studies lacking sufficient methodological details or appropriate controls.Results Psi has been recognized as a significant biomarker in cancer diagnosis and prognosis. Abnormal Psi modifications mediated by various PUSs result in dysregulated RNA metabolism and impaired RNA function, promoting the development of various cancers. Overexpression of PUSs is common in cancer cells and predicts poor prognosis. PUSs inhibition arrests cell proliferation and enhances apoptosis in cancer cells, suggesting PUS-targeting cancer therapy may be a potential strategy in cancer treatment.DiscussionHigh Psi levels in serum, urine, and saliva may suggest cancer, but do not specify the type, requiring additional lab markers and imaging for accurate diagnosis. Standardized detection methods are also crucial for reliable results. PUSs are linked to cancer, but more researches are needed to understand their mechanisms in different cancers. Anticancer treatments targeting PUSs are still under developed.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Telomere biology: Rationale for diagnostics and therapeutics in cancer
    Rousseau, Philippe
    Autexier, Chantal
    RNA BIOLOGY, 2015, 12 (10) : 1078 - 1082
  • [43] Prostate cancer immunology: Biology, therapeutics, and challenges
    Webster, WS
    Small, EJ
    Rini, BI
    Kwon, ED
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (32) : 8262 - 8269
  • [44] The redox biology network in cancer pathophysiology and therapeutics
    Manda, Gina
    Isvoranu, Gheorghita
    Comanescu, Maria Victoria
    Manea, Adrian
    Butuner, Bilge Debelec
    Korkmaz, Kemal Sami
    REDOX BIOLOGY, 2015, 5 : 347 - 357
  • [45] Impact of mouse models on cancer biology and therapeutics
    Nakamura, Takuro
    Yamada, Yasuhiro
    CANCER SCIENCE, 2021, 112 : 999 - 999
  • [46] RNA modifications in long non-coding RNAs and their implications in cancer biology
    Li, Jiexin
    Wang, Xiansong
    Wang, Hongsheng
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 113
  • [47] mTOR inhibitors as potential therapeutics for endometriosis: a narrative review
    Nakamura, Akiko
    Tanaka, Yuji
    Amano, Tsukuru
    Takebayashi, Akie
    Takahashi, Akimasa
    Hanada, Tetsuro
    Tsuji, Shunichiro
    Murakami, Takashi
    MOLECULAR HUMAN REPRODUCTION, 2024, 30 (12)
  • [48] Novel therapeutics in rare genetic obesities: A narrative review
    Dubern, Beatrice
    Faccioli, Nathan
    Poitou, Christine
    Clement, Karine
    PHARMACOLOGICAL RESEARCH, 2023, 191
  • [49] The Role of RNA Interference Therapeutics in Hypercholesterolemia and Implications for Practice
    DePhillips, Catherine
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2023, 19 (06):
  • [50] Prion biology: implications for Alzheimer's disease therapeutics Comment
    Condello, Carlo
    DeGrado, William F.
    Prusiner, Stanley B.
    LANCET NEUROLOGY, 2020, 19 (10): : 802 - +